TG Forum Logo TG Forum Logo

Spotlight on Lp(a) atherogenic mechanisms

You are here: Home > Journal updates
Spotlight on Lp(a) atherogenic mechanisms

Lp(a)-associated diacylglycerols (DAGs) and lysophosphatidic acid (LPA) have a potential role in Lp(a)-induced monocyte inflammation, according to new research investigating the atherogenicity of Lp(a).

Please login or create a FREE account to view this content

Other articles available on Lp(a) Forum

Pablo Corral

Should Lp(a) levels be measured more than once? 

New insights on Lp(a) testing around the world 

Should Lp(a) thresholds for CAD risk stratification be different for women and men? 

Educational Partners and Supporters

Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum. (Founding Partner)